Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 194–195 (2006)Cite this article

boxed-textJensen BE et al. (2005) Glucocorticoids do not influence the effect of radioiodine therapy in Graves' disease. Eur J Endocrinol 153: 15–21

Glucocorticoids can be used to prevent worsening of eye disease in patients with active Graves' ophthalmopathy without affecting the final outcome of radioiodine therapy on thyroid function

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Weetman AP (2000) Graves' disease. N Engl J Med 343: 1236–1248

    Article  CAS  Google Scholar 

  2. Bartalena L et al. (2000) Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 21: 168–199

    CAS  PubMed  Google Scholar 

  3. Bartalena L et al. (1998) Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338: 73–78

    Article  CAS  Google Scholar 

  4. Chiovato LE et al. (1998) Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab 83: 40–46

    CAS  PubMed  Google Scholar 

  5. Gamstedt A and Karlsson A (1991) Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: thyroid autoantibody responses and outcome of therapy. J Clin Endocrinol Metab 73: 125–131

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Assistant Professor Department of Molecular and Clinical Endocrinology and Oncology, Università degli Studi di Napoli “Federico II”, Naples, Italy

    Domenico Salvatore

  2. Professor of Endocrinology at the Department of Molecular and Clinical Endocrinology and Oncology, Università degli Studi di Napoli “Federico II”, Naples, Italy

    Gianfranco Fenzi

Authors
  1. Domenico Salvatore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gianfranco Fenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gianfranco Fenzi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salvatore, D., Fenzi, G. Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?. Nat Rev Endocrinol 2, 194–195 (2006). https://doi.org/10.1038/ncpendmet0163

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0163

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing